EventsMOL2NET'22, Conference on Molecular, Biomed., Comput. & Network Science and Engineering, 8th ed.
Event submissions
Published
with-doi10.3390/mol2net-08-12445
This submission belongs to the session 02. CHEMBIO.ORG-08: Org. Chem., Med. Chem., Mol. Biol., & Pharm. Industry Congress, Paris, France-Galveston, USA, 2022. of the event MOL2NET'22, Conference on Molecular, Biomed., Comput. & Network Science and Engineering, 8th ed.
Published date
23 Mar, 2022
Academic Editor
author-avatarHumbert G. Díaz
Citation
Luisa Chocarro, Ester Blanco, Hugo Arasanz, Leticia Fernández Rubio, Ana Bocanegra, Maider Garnica, Miriam Echaide, Sergio Piñeiro, Miren Zuazo, Ruth Vera, Grazyna Kochan, David Escors, Pablo Ramos, PD-L1/PD-1 Blockade Immunotherapy: Mechanism of response and resistance, in Proceedings of MOL2NET'22, Conference on Molecular, Biomed., Comput. & Network Science and Engineering, 8th ed., 1 January–15 January 2023, MDPI: Basel, Switzerland, doi: 10.3390/mol2net-08-12445
Share
Email
Facebook
Twitter
LinkedIn

PD-L1/PD-1 Blockade Immunotherapy: Mechanism of response and resistance

Luisa Chocarro 1
Ester Blanco 1,2
Hugo Arasanz 1,3
Leticia Fernández Rubio 1
Ana Bocanegra 1
Maider Garnica 1
Miriam Echaide 1
Pablo Ramos 1
Sergio Piñeiro 1
Miren Zuazo 1
Ruth Vera 3
Grazyna Kochan 1
David Escors 1
1. OncoImmunology Unit, Navarrabiomed-Fundacion Miguel Servet, Universidad Pública de Navarra (UPNA), Hospital Universitario de Navarra (HUN), Instituto de Investigación Sanitaria de Navarra (IdISNA), Pamplona, Navarra, Spain
2. Division of Gene Therapy and Regulation of Gene Expression, Cima Universidad de Navarra, Instituto de Investigación Sanitaria de Navarra (IdISNA), Pamplona, Spain
3. Medical Oncology Unit, Hospital Universitario de Navarra (HUN), Instituto de Investigación Sanitaria de Navarra (IdISNA), Pamplona, Navarra, Spain
Abstract
Keywords
PD-1
PD-L1
immunotherapy
treatment response
resistance mechanisms
Poster
MOL2NET'22 Chocarro PD-1.pdf
MOL2NET'22 Chocarro PD-1.pdf